To the editor: Uncompromised 10-year survival of oldest old carrying somatic mutations in DNMT3A and TET2

Blood

Volumn 127, Issue 11, 2016, Pages 1512-1515

  Van Den Akker, Erik B ^a,b   Pitts, Steven J ^c   Deelen, Joris ^a,d   Moed, Matthijs H ^a   Potluri, Shobha ^c   Van Rooij, Jeroen ^e   Suchiman, H Eka D ^a   Lakenberg, Nico ^a   De Dijcker, Wesley J ^a   Uitterlinden, André G ^e,f   Kraaij, Robert ^e,f   Hofman, Albert ^f   De Craen, Anton J M ^a   Houwing Duistermaat, Jeanine J ^a   Van Ommen, Gert Jan B ^a   Cox, David R ^c   Van Meurs, Joyce B J ^e   Beekman, Marian ^a,d   Reinders, Marcel J T ^b   Slagboom, P Eline ^a,d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^c PFIZER INC   (United States)

^d Netherlands Consortium for Healthy Ageing   (Netherlands)

^e Internal Medicine   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 3A; PROTEIN; TET2 PROTEIN; UNCLASSIFIED DRUG; DNA; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA BINDING PROTEIN; ONCOPROTEIN; TET2 PROTEIN, HUMAN;

AGE DISTRIBUTION; AGED; AMINO ACID SEQUENCE; COMORBIDITY; DNA DETERMINATION; DNA SEQUENCE; GENOME; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LETTER; LONG TERM SURVIVAL; LONGEVITY; META ANALYSIS (TOPIC); MUTATIONAL ANALYSIS; PREVALENCE; PRIORITY JOURNAL; SOMATIC MUTATION; VERY ELDERLY; AGING; BLOOD; COMPARATIVE STUDY; EPIDEMIOLOGY; FEMALE; FOLLOW UP; GENETICS; MALE; MUTATION; NETHERLANDS;

AGED; AGED, 80 AND OVER; AGING; DNA; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIESIS; HUMANS; LONGEVITY; MALE; MUTATION; NETHERLANDS; PROTO-ONCOGENE PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 84961821536     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-12-685925     Document Type: Letter

References (7)

1. Busque L, Patel JP, Figueroa ME, et al. Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nat Genet. 2012;44(11):1179-1181.
2. Xie M, Lu C, Wang J, et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med. 2014;20(12):1472-1478.
3. Genovese G, Kähler AK, Handsaker RE, et al. Clonal hematopoiesis and bloodcancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371(26):2477-2487.
4. Jaiswal S, Fontanillas P, Flannick J, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488-2498.
5. Hofman A, van Duijn CM, Franco OH, et al. The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol. 2011;26(8):657-686.
6. Schoenmaker M, de Craen AJ, de Meijer PH, et al. Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study. Eur J Hum Genet. 2006;14(1):79-84.
7. Forbes SA, Beare D, Gunasekaran P, et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res. 2015;43(database issue):D805-D811.